LINDSEY WONDOLOSKI: Open Payments
NPI 1912664053 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,380 in 122 payments from 18 companies in 2025. Trend: 2023 $2,171 · 2024 $2,234 · 2025 $2,380
Food & beverage: $2,380
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 22 | $497 |
| Teva Pharmaceuticals USA, Inc. | 14 | $245 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $232 |
| Alkermes, Inc. | 12 | $211 |
| Otsuka America Pharmaceutical, Inc. | 8 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $150 |
| Axsome Therapeutics, Inc. | 7 | $144 |
| Janssen Pharmaceuticals, Inc | 5 | $136 |
| Corium, LLC | 4 | $115 |
| ABBVIE INC. | 5 | $103 |
Products named: INGREZZA, REXULTI, AUSTEDO XR, CAPLYTA, TRINTELLIX, Auvelity, SPRAVATO, Azstarys.
Industry payments across TN — which companies pay providers there.
